A gene therapy developed by researchers at UT Southwestern Medical Center for a rare disease called giant axonal neuropathy (GAN) was well tolerated in pediatric patients and showed clear benefits, a new study reports.

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to results of a phase two clinical trial conducted by UT Southwestern Medical Center.

UT Southwestern Medical Center researchers have identified a compound that selectively eliminates cancer cells while sparing immune cells in a form of cell death known as ferroptosis.

Marilyn Gibson, 81, is part of a UT Southwestern Medical Center clinical trial testing a one-time, high-dose and highly focused radiation treatment called stereotactic radiotherapy for early-stage breast cancer.

The family’s hope for Willow stems from a gene therapy center at UT Southwestern Medical Center where leading experts are engineering innovative treatments for some of the world’s rarest brain diseases.

A new study of measuring blood pressure at home in U.S. populations has found that the ideal level is 130 over 80 or lower.

By injecting patients with stem cells engineered to repair the central nervous system – called progenitor cells – UT Southwestern scientists are working to establish the first treatment that can repair spinal cords inflamed by transverse myelitis.

UT Southwestern’s O’Donnell Brain Institute will help in a national effort to understand the neural circuits behind learning, memory, and behavior.

The March 21 decision by NCCN to include the Simmons Cancer Center among its members recognizes Simmons Cancer Center’s elite status and will deepen its collaboration with national peers at the highest levels.

Researchers at the Kidney Cancer Program at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center have developed what could be the most complete catalog of clear cell renal cell carcinoma, the most common type of kidney cancer.